Sunitix

Sunitix is Sunitinib, an oral multi-targeted tyrosine kinase inhibitor. It is indicated for renal cell carcinoma, gastrointestinal stromal tumor, and pancreatic neuroendocrine tumors and works by inhibiting angiogenic and proliferative kinase pathways.

Features